SCHEMBL14638232

SCHEMBL14638232

CCOC(=O)Nc1ccc(N(F)Cc2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
RAB9A P51151 6/20 0.48
NPC1 O15118 5/20 0.48
KMT2A Q03164 3/20 0.47
MAPT P10636 7/20 0.46
POLB P06746 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 4/20 0.45
SMN1; SMN2 Q16637 6/20 0.45
MAPK1 P28482 3/20 0.45
KCNQ4 P56696 1/20 0.45
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
AR P10275 1/20 0.43
KCNQ2 O43526 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20129843 0.85 PKM (0.46) PKML3MBTL1RAB9ANPC1KMT2A
SCHEMBL20129857 0.82 MAPT (0.49) PKML3MBTL1RAB9ANPC1KMT2A
SCHEMBL1826738 0.82 KCNQ2 (0.60) RAB9ANPC1KMT2AMAPTALDH1A1
SCHEMBL20129854 0.82 NPC1 (0.46) PKML3MBTL1RAB9ANPC1KMT2A
SCHEMBL15172817 0.81 MAPT (0.55) L3MBTL1KMT2AMAPTNPSR1ALDH1A1
SCHEMBL20129856 0.78 PKM (0.41) PKML3MBTL1RAB9ANPC1KMT2A
SCHEMBL17761732 0.78 ALDH1A1 (0.60) PKML3MBTL1RAB9ANPC1KMT2A
SCHEMBL8966767 0.78 KCNQ3 (0.54) PKML3MBTL1RAB9ANPC1KMT2A
SCHEMBL15538708 0.78 MAPT (0.52) PKML3MBTL1RAB9ANPC1KMT2A
SCHEMBL20129848 0.78 THRB (0.42) PKML3MBTL1RAB9ANPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013011518-A1 PROCESS FOR THE PREPARATION OF RETIGABINE OF THE FORMULA I AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF ARCH PHARMALABS LIMITED (IN) 2013-01-24 WO claimed